Research Article   
MENTAL HEALTH TREATMENT AND METABOLIC DISORDERS IN PREGNANCY: A LONGITUDINAL STUDY
Author(s): Carolyn Breadon*, Shalini Arunogiri, Alisa Turbic, Alex Lavale, Ricardo Maldonado and Jayashri Kulkarni AM Fahms Objective: This study aimed to measure sequential rates of obesity, gestational diabetes, polycystic ovary syndrome, and anxiety, depression, and antidepressant treatment in pregnant women in Australia between 2008 and 2022. Materials and Methods: BMI ≥ 30 (obesity), BMI ≥ 35 (severe obesity/obesity class II and III), gestational diabetes, Type II diabetes, polycystic ovary syndrome, clinical diagnoses of anxiety and depression, antidepressant treatment. Results: Women taking antidepressants in pregnancy were substantially more vulnerable to obesity (BMI ≥ 30) with rates of 43.59% vs 26.00%. Women taking antidepressants in pregnancy also had higher rates of severe obesity (BMI ≥ 35) at 25.63% vs 12.98%. A small minority of these women were also nearly 6 times more likely to drink alcohol in pregnancy (2.. Read More» DOI: 10.54615/2231-7805.47357

Abstract HTML PDF